Content area

Abstract

Maintaining microbiome structure is critical for the health of both plants and animals. By re-screening a collection of Arabidopsis mutants affecting root immunity and hormone crosstalk, we identified a FERONIA (FER) receptor kinase mutant (fer-8) with a rhizosphere microbiome enriched in Pseudomonas fluorescens without phylum-level dysbiosis. Using microbiome transplant experiments, we found that the fer-8 microbiome was beneficial. The effect of FER on rhizosphere pseudomonads was largely independent of its immune scaffold function, role in development and jasmonic acid autoimmunity. We found that the fer-8 mutant has reduced basal levels of reactive oxygen species (ROS) in roots and that mutants deficient in NADPH oxidase showed elevated rhizosphere pseudomonads. The addition of RALF23 peptides, a FER ligand, was sufficient to enrich P. fluorescens. This work shows that FER-mediated ROS production regulates levels of beneficial pseudomonads in the rhizosphere microbiome.

A genetic screen identifies the versatile membrane receptor protein FERONIA as a key modulator of rhizosphere Pseudomonas and microbiome composition in Arabidopsis, through the control of basal levels of reactive oxygen species production.

Details

Title
FERONIA restricts Pseudomonas in the rhizosphere microbiome via regulation of reactive oxygen species
Author
Song, Yi 1 ; Wilson, Andrew J 2   VIAFID ORCID Logo  ; Xue-Cheng, Zhang 3 ; Thoms, David 1 ; Sohrabi Reza 4 ; Song Siyu 2   VIAFID ORCID Logo  ; Geissmann Quentin 1   VIAFID ORCID Logo  ; Liu, Yang 2 ; Walgren Lauren 2   VIAFID ORCID Logo  ; He Sheng Yang 5 ; Haney, Cara H 1   VIAFID ORCID Logo 

 The University of British Columbia, Department of Microbiology and Immunology, Vancouver, Canada (GRID:grid.17091.3e) (ISNI:0000 0001 2288 9830); The University of British Columbia, Michael Smith Laboratories, Vancouver, Canada (GRID:grid.17091.3e) (ISNI:0000 0001 2288 9830) 
 The University of British Columbia, Department of Microbiology and Immunology, Vancouver, Canada (GRID:grid.17091.3e) (ISNI:0000 0001 2288 9830) 
 Massachusetts General Hospital, Department of Molecular Biology, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924); Harvard Medical School, Department of Genetics, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); DermBiont, Boston, USA (GRID:grid.38142.3c) 
 Michigan State University, Department of Energy Plant Research Laboratory, East Lansing, USA (GRID:grid.17088.36) (ISNI:0000 0001 2150 1785) 
 Michigan State University, Department of Energy Plant Research Laboratory, East Lansing, USA (GRID:grid.17088.36) (ISNI:0000 0001 2150 1785); Duke University, Department of Biology, Durham, USA (GRID:grid.26009.3d) (ISNI:0000 0004 1936 7961); Duke University, Howard Hughes Medical Institute, Durham, USA (GRID:grid.26009.3d) (ISNI:0000 0004 1936 7961) 
Pages
644-654
Publication year
2021
Publication date
May 2021
Publisher
Nature Publishing Group
e-ISSN
20550278
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2528635525
Copyright
© The Author(s), under exclusive licence to Springer Nature Limited 2021.